Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
515 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 65.37 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 56.74 | Oscillator | Neutral |
| Williams %R (14) | -40.34 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.86 (Hist 0.13) | Oscillator | Strong Buy |
| Average Directional Index (14) | 16.07 (+DI 26.7 / -DI 18.3) | Trend | Neutral |
Current price $51.00
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 6, 26 | Raymond James |
| EMA 20 | 49.08 | MA | Strong Buy |
| SMA 20 | 48.82 | MA | Strong Buy |
| EMA 50 | 47.50 | MA | Strong Buy |
| SMA 50 | 47.51 | MA | Strong Buy |
| SMA 200 | 40.09 | MA | Strong Buy |
| upgrade |
| Market Perform |
| Outperform |
| Aug 3, 26 | Piper Sandler | maintain | Neutral | Neutral |
| Jan 7, 26 | Raymond James | downgrade | Strong Buy | Market Perform |
| Jul 29, 25 | Piper Sandler | maintain | Neutral | Neutral |
| May 29, 25 | Piper Sandler | downgrade | Overweight | Neutral |
| Mar 20, 25 | Piper Sandler | maintain | Overweight | Overweight |
| Jan 30, 25 | Raymond James | maintain | Strong Buy | Strong Buy |
| Jan 29, 25 | Piper Sandler | maintain | Overweight | Overweight |
| Oct 30, 24 | Piper Sandler | maintain | Overweight | Overweight |
Stock news · updated daily
Chain Bridge Bancorp, Inc. (CBNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chain Bridge Bancorp, Inc. (CBNA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 26, 26 | Evinger David M. | director, officer: President, Chief Risk Officer | G-Gift | 340 | — |
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 28, 2026 | 1.24 | 1.45 | Beat 16.9% | $20.00M |
| Apr 28, 2026 | 0.95 | 1.08 | Beat 13.7% | $17.37M |
| Jan 28, 2026 | 0.79 | 0.81 | Beat 2.5% | $14.70M |
| Oct 28, 2025 | 0.70 | 0.72 | Beat 2.9% | $14.29M |
| Jul 28, 2025 | 0.44 | 0.70 | Beat 59.1% | $13.62M |
| Apr 28, 2025 | 0.54 | 0.85 | Beat 57.4% | $15.46M |
| Aug 26, 26 |
| Evinger David M. |
| director, officer: President, Chief Risk Officer |
| G-Gift |
| 340 |
| — |
| Jul 29, 26 | Martinelli Mark | director | P-Purchase | 400 @ $44.00 | $17.60K |
| Mar 6, 26 | Basha Leigh-Alexandra | director | P-Purchase | 400 @ $35.04 | $14.02K |
| Nov 18, 25 | Basha Leigh-Alexandra | director | P-Purchase | 400 @ $30.48 | $12.19K |
| Mar 5, 26 | Pollock James R. | officer: Corporate Development Officer | P-Purchase | 714 @ $35.25 | $25.17K |
| Nov 18, 25 | Basha Leigh-Alexandra | director | P-Purchase | 400 @ $30.48 | $12.19K |
| Jun 29, 25 | Basha Leigh-Alexandra | director | P-Purchase | 400 @ $29.97 | $11.99K |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 8-K | Aug 31, 2026 | 2026-08-31 17:00:15 | View |
| 4 | Aug 28, 2026 | 2026-08-28 10:08:09 | View |
| 10-Q | Aug 11, 2026 | 2026-08-11 11:33:19 | View |
| 4 | Jul 31, 2026 | 2026-07-31 16:02:33 | View |
| 8-K | Jul 28, 2026 | 2026-07-28 16:17:52 | View |
| 8-K | Jul 20, 2026 | 2026-07-20 17:02:15 | View |
| SC 13G | Jul 20, 2026 | 2026-07-20 13:21:17 | View |
| 8-K | Jun 18, 2026 | 2026-06-18 12:06:17 | View |
| 10-Q | May 12, 2026 | 2026-05-12 15:08:11 | View |
| 8-K | Apr 28, 2026 | 2026-04-28 16:15:30 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | CBNA | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 12.6x | 13.3x · sector 20.4x | Discount |
| Forward P/E (FY26E) | 9.9x | EPS est. 5.16 | Discount |
| Price / Book | 1.8x | 1.5x | Elevated |
| Price / Sales | 5.1x | 3.8x | Elevated |
| EV / EBITDA | 10.6x | -7.2x | Discount |
| Return on equity | 15.4% | — | Healthy |
| Gross margin | 95.0% | 93.7% | In line |
| Debt / Equity | 0.00 | 0.03 | Conservative |
| Piotroski / Altman Z | 5/9 | Z -0.38 | Distress |
Discounted cash flow model